Role of microRNA-761 in modulating laryngeal cancer cell proliferation, metastasis, and apoptosis: regulation of PDCD4 as a key mechanism
Molecular Biology Reports · 2025
DOI: 10.1007/s11033-025-11083-0 ↗Kurz gefasst
Fachartikel in der Zeitschrift Molecular Biology Reports, 2025. Verfasst von Ruiqing Chen und 4 weiteren Autor:innen. Beteiligte Einrichtung: Central Laboratory, The First Affiliated Hospital of Fujian Medical University, Fuzhou, 350005, China. crq209ted@fjmu.edu.cn. Hauptthemen laut MEDLINE: MicroRNAs, Laryngeal Neoplasms, Apoptosis Regulatory Proteins, RNA-Binding Proteins. Die Arbeit nennt 41 Literaturangaben. Gefördert von: Fujian Natural Fund Project.
Abstract (Originalsprache)
BACKGROUND: Laryngeal cancer is a leading global cause of cancer-related mortality. The regulatory interplay between dysregulated microRNA-761 (miR-761) and oncogenic signaling pathways in laryngeal carcinogenesis has not been fully elucidated. METHODS: This study explored the interaction between miR-761 and programmed cell death protein 4 (PDCD4) through dual-luciferase assay, cell proliferation and migration assays, and xenograft models. RESULTS: MiR-761 was significantly upregulated in laryngeal cancer tissues and cell lines, inversely correlating with PDCD4 downregulation. Computational predictions and dual-luciferase assays confirmed that miR-761 targets the 3'-UTR of PDCD4, inhibiting its transcription. Functional studies showed that miR-761 knockdown restored PDCD4 expression, increasing apoptosis and reducing proliferation and migration. Conversely, miR-761 overexpression enhanced these capacities in PDCD4-low cancer cells, effects reversed by PDCD4 upregulation. In vivo xenograft models demonstrated that miR-761 inhibition reduced tumor growth, with increased PDCD4 expression. CONCLUSIONS: MiR-761 is a critical regulator of PDCD4, modulating laryngeal cancer progression through apoptosis inhibition and pro-metastatic signaling. Targeting the miR-761/PDCD4 axis offers a promising therapeutic strategy for laryngeal cancer management.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Central Laboratory, The First Affiliated Hospital of Fujian Medical University, Fuzhou, 350005, China. crq209ted@fjmu.edu.cn.
- Key Laboratory of Radiation Biology of Fujian Higher Education Institutions, The First Affiliated Hospital of Fujian Medical University, Fuzhou, 350005, China. crq209ted@fjmu.edu.cn.
- Central Laboratory, National Regional Medical Center, Binhai Campus of the First Affiliated Hospital of Fujian Medical University, Fuzhou, 350005, China. crq209ted@fjmu.edu.cn.
- Central Laboratory, The First Affiliated Hospital of Fujian Medical University, Fuzhou, 350005, China.
- Key Laboratory of Radiation Biology of Fujian Higher Education Institutions, The First Affiliated Hospital of Fujian Medical University, Fuzhou, 350005, China.
- Central Laboratory, National Regional Medical Center, Binhai Campus of the First Affiliated Hospital of Fujian Medical University, Fuzhou, 350005, China.
Förderung
- Fujian Natural Fund Project
Zitieren
APA
Chen, R., Wang, Z., Wu, B., Liu, D., & Xu, Y. (2025). Role of microRNA-761 in modulating laryngeal cancer cell proliferation, metastasis, and apoptosis: regulation of PDCD4 as a key mechanism. Molecular Biology Reports. https://doi.org/10.1007/s11033-025-11083-0
Vancouver
Chen R, Wang Z, Wu B, Liu D, Xu Y. Role of microRNA-761 in modulating laryngeal cancer cell proliferation, metastasis, and apoptosis: regulation of PDCD4 as a key mechanism. Molecular Biology Reports. 2025. doi:10.1007/s11033-025-11083-0
BibTeX
@article{Chen2025,
author = {Chen, Ruiqing and Wang, Zeng and Wu, Bing and Liu, Dangqing and Xu, Yuanteng},
title = {Role of microRNA-761 in modulating laryngeal cancer cell proliferation, metastasis, and apoptosis: regulation of PDCD4 as a key mechanism},
journal = {Molecular Biology Reports},
year = {2025},
doi = {10.1007/s11033-025-11083-0}
}
EUVIMED